New Current Report Filed with the SEC Disclosing Receipt of a Notice of Delisting, the Failure to Satisfy a Continued Listing Rule or Standard or the Transfer of a Listing: 8-K – Fibrocell Science, Inc. (0000357097) (Filer)





A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) disclosing receipt of a notice of delisting, the failure to satisfy a continued listing rule or standard or the transfer of a listing. Details of the current report are:

8-K – Fibrocell Science, Inc. (0000357097) (Filer)
Filed: 2016-10-05 AccNo: 0000357097-16-000191 Size: 3 MB

Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item 7.01: Regulation FD Disclosure

Item 9.01: Financial Statements and Exhibits
Filing Date: 2016-10-05T16:03:07-04:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: http://www.sec.gov/Archives/edgar/data/357097/000035709716000191/0000357097-16-000191-index.htm